Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 2 Tumor entities and location in the two study groups
Tumor entity | Control group (n = 53) | Intervention group (n = 79) |
|---|---|---|
Osteosarcoma, n (%) | 25 (47%) | 28 (35%) |
Metastasis, n (%) | 4 (8%) | 21 (27%) |
Ewing sarcoma, n (%) | 10 (19%) | 12 (15%) |
Chondrosarcoma, n (%) | 8 (15%) | 7 (9%) |
Myxofibrosarcoma, n (%) | 0 (0%) | 3 (4%) |
Giant cell tumor, n (%) | 2 (4%) | 2 (3%) |
Other, n (%) | 4 (8%) | 6 (8%) |
Tumor location | ||
Upper arm | ||
Proximal upper arm, n (%) | 12 (22.6%) | 6 (7.6%) |
Distal upper arm, n (%) | 0 (0%) | 1 (1.3%) |
Total upper arm, n (%) | 1 (1.9%) | 0 (0%) |
Forearm | ||
Proximal forearm, n (%) | 1 (1.9%) | 0 (0%) |
Distal forearm, n (%) | 0 (0%) | 0 (0%) |
Thigh | ||
Proximal thigh, n (%) | 17 (32.0%) | 20 (25.3%) |
Distal thigh, n (%) | 14 (26.4%) | 27 (34.2%) |
Total thigh, n (%) | 5 (9.4%) | 9 (11.4%) |
Total knee, n (%) | 0 (0%) | 2 (2.5%) |
Lower leg | ||
Proximal lower leg, n (%) | 2 (3.8%) | 13 (16.5%) |
Distal lower leg, n (%) | 1 (1.9%) | 1 (1.3%) |